Flavone-8-acetic acid (Flavonoid) profoundly reduces platelet-dependent thrombosis and vasoconstriction after deep arterial injury in vivo

Circulation

Volumn 101, Issue 3, 2000, Pages 324-328

  Mruk, Jozef S ^a   Webster, Mark W I ^b   Heras, Magda ^c   Reid, Joel M ^d   Grill, Diane E ^d   Chesebro, James H ^e  

^a Buchanan County Cardiology PC   (United States)

^b GREEN LANE HOSPITAL   (New Zealand)

^c HOSPITAL CLÍNIC   (Spain)

^d MAYO CLINIC   (United States)

^e MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Angioplasty; Platelet aggregation inhibitors; Platelets; Thrombus; Vasoconstriction

Indexed keywords

ANTINEOPLASTIC AGENT; FIBRINOGEN; MITOFLAXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY INJURY; ARTICLE; BLEEDING TIME; CAROTID ARTERY THROMBOSIS; CONTROLLED STUDY; DRUG EFFICACY; FIBRIN DEPOSITION; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; SWINE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS PREVENTION; TREATMENT OUTCOME;

EID: 0034711686     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.3.324     Document Type: Article

References (37)

1. Hawiger J, Kloczewiak M, Timmons S. Platelet-receptor mechanisms for adhesive macromolecules. In: Interactions of Platelets With the Vessel Wall. Bethesda, Md: American Physiological Society; 1985:1-19.
2. Hawiger J. Formation and regulation of platelet and fibrin hemostatic plug. Hum Pathol. 1987;18:111-122.
3. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIb-IIIa complex. Blood. 1988;71:831-843.
4. Kroll MH, Schafer AI. Biochemical mechanisms of platelet activation. Blood. 1989;74:1181-1195.
5. Frenette PS, Wagner DD. Molecular medicine: adhesion molecules, part I. N Engl J Med. 1996;33:1526-1529.
6. Frenette PS, Wagner DD. Adhesion molecules, part II: blood vessels and blood cells. N Engl J Med. 1996;335:43-45.
7. Lefkovits J, Topol EJ. The clinical role of platelet glycoprotein IIb/IIIa receptor inhibitors in ischemic heart disease. Cleve Clin J Med. 1996;63: 181-189.
8. Becker RC. Antiplatelet therapy. Sci Med. 1996;3:12-22.
9. Ruggeri Z. Mechanisms initiating platelet thrombus formation. Thromb Haemost. 1997;78:611-616.
10. Armand JP, De Forni M, Recondo G, Cals L, Cvitkovic E, Munck JN. Flavonoids: a new class of anticancer agents? Preclinical and clinical data of flavone acetic acid. In: Cody V, Harborne JG, Middleton E, eds. Plant Flavonoids in Biology and Medicine II: Biochemical Cellular, and Medicinal Properties. New York: John Wiley & Sons, 1988:235-241.
11. Kerr DJ, Kaye SB. Flavone acetic acid: preclinical and clinical activity. Eur J Cancer Clin Oncol. 1989;25:1271-1272.
12. Rubin J, Ames MM, Schutt AJ, Nichols WL, Bowie EJ, Kovach JS. Flavone-8-acetic acid inhibits ristocetin-induced platelet agglutination and prolongs bleeding time. Lancet. 1987;2:1081-1082.
13. Altman PL, Dittmer DS. Metabolism. In: Biological Handbooks. Bethesda. Md: Federation of American Societies for Experimental Biology; 1968:346-348.
14. Steele PM, Chesebro JH, Stanson AW, Holmes DR, Dewanjee MK, Badimon L, Fuster V. Balloon angioplasty: natural history of the pathophysiologic response to injury in a pig model. Circ Res. 1985;57:105-112.
15. Heras M, Chesebro JH, Webster MWI, Mruk JS, Grill DE, Penny WJ, Bowie EJW, Badimon L, Fuster V. Hirudin, heparin, and placebo during deep arterial injury in the pig: the in vivo role of thrombin in platelet-mediated thrombosis. Circulation. 1990;82:1476-1484.
16. Lam JYT, Chesebro JH, Steele PM, Badimon L, Fuster V. Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. Circulation. 1987;75:243-248.
17. Mruk J, Zoldhelyi P, Webster M, Heras M, Grill D, Holmes DR, Fuster V, Chesebro JH. Does anti-thrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin. Circulation. 1996;93:792-799.
18. Sawada Y, Fass DN, Katzmann JA, Bahn RC, Bowie EJW. Hemostatic plug formation in normal and von Willebrand pigs: the effect of the administration of cryoprecipitate and a monoclonal antibody to Willebrand factor. Blood. 1986;67:1229-1239.
19. Dewanjee MK. Methods of assessment of thrombosis in vivo. Ann NY Acad Sci. 1987;516:541-571.
20. Dewanjee MK, Tago K, Josa M, Fuster V, Kaye MP. Quantification of platelet retention in aortocoronary femoral vein bypass graft in dogs treated with dipyridamole and aspirin. Circulation. 1984;69:350-356.
21. Smith GP, Calveley SB, Smith MJ, Baguley BC. Flavone acetic acid (NSC 347512) induces hemorrhagic necrosis of mouse colon 26 and 38 tumors. Eur J Cancer Clin Oncol. 1987;23:1209-1211.
22. Hill S, Williams KB. Denekamp J. Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumor action. Eur J Cancer Oncol. 1989;25:1419-1424.
23. Murray JC, Smith KA, Thurston G. Flavone acetic acid induces a coagulopathy in mice. Br J Cancer. 1989;60:729-733.
24. Thurston G, Smith KA, Murray JC. Anticoagulant treatment does not effect the action of flavone acetic acid in tumor-bearing mice. Br J Cancer. 1991;64:689-692.
25. Murray JC, Clauss M, Denekamp J, Stem D. Selective induction of endothelial cell tissue factor in the presence of a tumor-derived mediator: a potential mechanism of flavone acetic acid action in tumor vasculature. Int J Cancer. 1991;49:254-259.
26. Murray JC, Smith KA, Stern DM. Flavone acetic acid potentiates the induction of endothelial procoagulant activity by tumor necrosis factor. Eur J Cancer. 1991;27:765-770.
27. Ruoslahti E, Pierschbacher D. New perspectives in cell adhesion: RGD and integrins. Science. 1987;238:491-497.
28. De Marco L, Mazzucato M, Masotti A, Ruggeri ZM. Localization and Characterization of an α-thrombin-binding site on platelet glycoprotein Ibα. J Biol Chem. 1994;283:6478-6484.
29. Gralnick HR, Williams S, McKeown LP, Hansmann K, Fenton JW II. Krutzsch H. High-affinity α-thrombin binding to platelet glycoprotein Ibα: identification of two binding domains. Proc Natl Acad Sci U S A. 1994;91:6334-6338.
30. Couglin SR, Vu TKH, Hung DT, Wheaton VI. Characterization of a functional thrombin receptor. J Clin Invest. 1992;89:351-355.
31. McNicol A, Sutherland M, Zou R, Drouin J. Defective thrombin-induced calcium changes and aggregation of Bernard-Soulier platelets are not associated with deficient moderate-affinity receptors. Atheroscler Thromb Vasc Biol. 1996;16:628-632.
32. Thomsen LL, Ching LM, Bauley BC. Evidence for the production of nitric oxide by activated macrophages treated with antitumor agents flavone-8-acetic acid and xantherone-4-acetic acid. Cancer Res. 1990;50: 6966-6970.
33. Watts ME, Murray JC, Smith KA, Woodcock M. Flavone acetic acid as a modifier of endothelial cell function. Int J Radiat Oncol Biol Phys. 1992;22:431-435.
34. Fitzpatrick DF, Hirschfield SL, Coffey RG, Endothelium-dependent vasoreacting activity of wine and other grape products. Am J Physiol. 1993;265:H774-778.
35. Tousoulis D, Tentolouris C, Bosinakou E, Apostolopoulos T, Toutouzas P. Inhibition of cyclic flow variations by von Willebrand factor: glycoprotein Ib binding domain. Circulation. 1996;93:1255. Letter.
36. McGhie IA, McNatt J, Ezov N, Cui K, Mower L, Hagay Y, Buja MJ, Garfinkel LI, Goreski M, Willerson JT. Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in non-human primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domain. Circulation. 1994;90: 2976-2981.
37. Murata M, Matsubara Y, Kawano K, Zama T, Aokd N, Yoshimo H, Watnabe G, Ishikawa K, Ikeda Y. Coronary artery disease and polymorphism in receptor mediating shear stress-dependent platelet activation. Circulation. 1997;96:3281-3286.